HemaSphere (Jun 2022)

P1689: TISSUE-SELECTIVE PHARMACOLOGICAL TARGETING OF TUMOR INTRINSIC PROTHROMBIN (F2) EXPRESSION USING AN INTEGRATED GENETIC REPORTER SYSTEM

  • E. Khan,
  • J. Nourse,
  • S. Tokalov,
  • S. Khokhar,
  • D. Arnold-Schild,
  • L. Schott,
  • L. Eder,
  • S. Danckwardt

DOI
https://doi.org/10.1097/01.HS9.0000849612.93722.61
Journal volume & issue
Vol. 6
pp. 1570 – 1571

Abstract

Read online

No abstracts available.